Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | AMGN | GILD | CELG | VRTX |
| Company | Repligen Corp | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 145.27 | 337.03 | 84.39 | 108.01 | 477.70 |
| High | 150.84 | 338.70 | 84.65 | 108.59 | 483.98 |
| Low | 144.33 | 334.61 | 83.43 | 107.27 | 476.27 |
| Last | 145.78 | 335.95 | 83.90 | 108.24 | 477.90 |
| Change | +3.75 | +3.03 | +0.01 | +0.11 | +3.74 |
| % Change | +2.64% | +0.91% | +0.01% | +0.10% | +0.79% |
| Volume | 695,100 | 1,626,200 | 8,798,200 | 191,230,496 | 939,900 |
| 20-Day Average Volume | 836,875 | 1,760,685 | 6,694,930 | 16,188,930 | 987,030 |
| Previous Close | 142.03 | 332.92 | 83.89 | 108.13 | 474.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 144.69 | 329.59 | 80.07 | 108.17 | 479.86 |
| 20-Day Raw Stochastic | 56.25% | 84.75% | 89.62% | 63.25% | 43.50% |
| 20-Day Relative Strength | 49.95% | 57.67% | 71.87% | 64.69% | 49.36% |
| Weighted Alpha | -15.04 | +27.09 | +18.24 | +46.30 | +33.54 |
| Today's Opinion | 72% Sell | 96% Buy | 88% Buy | 100% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 88% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 40% Sell | 88% Buy | 56% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.71% since 09/12/24 | +1.78% since 09/12/24 | +0.89% since 09/12/24 | -1.97% since 11/13/19 | -0.16% since 09/12/24 |
| Low | 135.88 on 09/17/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 473.75 on 09/18/24 |
| High | 150.84 on 09/19/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | -5.23% since 08/19/24 | +2.43% since 08/19/24 | +12.69% since 08/19/24 | +5.14% since 10/18/19 | -2.08% since 08/19/24 |
| Low | 135.88 on 09/17/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 460.69 on 09/11/24 |
| High | 154.17 on 08/20/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +18.52% since 06/18/24 | +9.79% since 06/18/24 | +32.86% since 06/18/24 | +13.63% since 08/20/19 | +2.27% since 06/18/24 |
| Low | 113.50 on 06/20/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 458.04 on 08/13/24 |
| High | 172.65 on 08/01/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -26.63% since 03/19/24 | +23.63% since 03/19/24 | +14.29% since 03/19/24 | +14.14% since 05/20/19 | +15.10% since 03/19/24 |
| Low | 113.50 on 06/20/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 391.01 on 04/18/24 |
| High | 200.23 on 03/21/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,936,067 | 178,589,936 | 104,514,608 | 77,035,920 | 122,358,416 |
| Shares Outstanding, K | 55,876 | 536,435 | 1,245,853 | 711,714 | 258,053 |
| Annual Sales | 638,760,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 41,580,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 154,070,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 2,645,600,000 |
| Last Quarter Net Income | 3,320,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -3,593,600,000 |
| 60-Month Beta | 0.94 | 0.61 | 0.18 | 1.41 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.33 on 07/30/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | -12.83 on 08/01/24 |
| Latest Earnings Date | 10/29/24 | 10/29/24 | 11/05/24 | 10/31/19 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 116.57 | 17.89 | 17.67 | 10.99 | 0.00 |